Consulting | Scientific & Medical Communications | Commercial Communications
Lucid Group, a global leader in healthcare communications and commercialization, proudly announces the launch of Lucid Group US—a strategic unification of its US agencies, Lighthouse and DiD, under a single, integrated entity, representing a bold step forward in achieving Lucid’s mission of transforming lives.
Under the leadership of Bill Fay, President of Lucid Group US, this evolution strengthens Lucid’s position as a trusted partner for Life Science and Consumer Health brands.
Arriel Mecca, Bill Fay, Nina Leeds, Ify Onyeaso, Cailine Petzold from Lucid Group US
Lucid Group US's capabilities are expanding — providing clients with even broader access to integrated expertise across medical communications, commercial strategy, creative storytelling, behavioral science, advanced analytics, targeted media, and omnichannel engagement. Clients will also benefit from new AI-enabled capabilities that enhance efficiency and impact.
“Breakthrough science doesn’t commercialize itself,” said Bill Fay. “In today’s crowded and complex healthcare environment, clients need more than just marketing campaigns—they need conviction. Lucid Group US was designed to meet that need. We bring scientific expertise, commercial ingenuity, behavioral insight, and storytelling precision to shape how your asset is seen, understood, and embraced in the market.”
Lucid Group US is built for today’s fast-moving market—and tomorrow’s, combining decades of medical and commercial communications expertise in Life Sciences and Consumer Health. Lucid’s integrated team of scientists, strategists, and creatives work seamlessly to help clients’ assets break through and achieve lasting impact in the market. Whether it’s launching a first-in-class therapy, revitalizing a mature brand, or navigating competitive headwinds, Lucid Group US delivers with agility, efficiency, and precision.
“In a market where 70% of healthcare brands fall short of expectations, we must ask: how can we do better? At Lucid Group, we take this challenge personally,” added Fay. “With our deep therapeutic expertise and data driven strategies, we help clients uncover unseen risks and untapped opportunities—moving them from clinical promise to market leadership.
We’re about accelerating adoption wherever clients are in the asset lifecycle, building conviction, and ensuring our clients’ innovations achieve their rightful place in the market. That’s the power of our fully integrated team; all focused on one outcome: creating belief that drives action.”
Lucid Group US’s culture unlocks the full potential of its people (with 95% of employees saying they can be themselves at work every day), enabling diverse expertise and creativity to power its mission of transforming lives. Lucid Group’s impact extends to sustainability, ranking in the 94th percentile globally via EcoVadis for its commitment to environmental responsibility and a healthier future.
The launch of Lucid Group US marks a new chapter, uniting cross-disciplinary expertise to help clients navigate complexity, accelerate progress, and deliver lasting impact for patients, transforming lives with every step.
Bill Fay
President, Lucid Group US
Bill.Fay@wearelucidgroup.com